ArticleBMC medical imaging2026
An interpretable machine learning model based on habitat radiomics combined with deep learning for predicting the WHO/ISUP grade of patients with clear cell renal cell carcinoma.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aims to explore spatial heterogeneity within tumors, establish and validate an interpretable machine learning model combining habitat radiomics and deep learning, and investigate its predictive value for the World Health Organization/International Society of Urological Pathology (WHO/ISUP) grading system for clear cell renal cell carcinoma (ccRCC).
methodsA total of 646 patients participated in this retrospective study. Enhanced CT cortical phase images, clinical characteristics, and imaging features were collected. Habitat regions were generated using K-means clustering. Intra-tumor (Intra), habitat (Habitat), 2D and 2.5D deep learning (DL) models were developed. Independent predictive factors were identified through univariate and multivariate regression analysis, and a logistic regression (LR) classifier was integrated into a fusion model. Model performance was assessed using SHapley additive explainability (SHAP) analysis.
resultsAge, tumor size, and necrosis emerged as independent predictors. The habitat radiomics model demonstrated superior performance to the intratumoral and 2.5D models, with validation and test set AUCs of 0.854 (95% CI: 0.795–0.905) and 0.862 (95% CI: 0.785–0.915), respectively. The fusion model achieved optimal performance, yielding AUCs of 0.901 (95% CI: 0.850–0.948) and 0.913 (95% CI: 0.857–0.960) for the validation and test sets. Calibration curves confirmed high predictive accuracy, while decision curve analysis (DCA) revealed greater clinical utility for the fusion model. SHAP interpretability elucidated feature contributions to model predictions.
conclusionsThe fusion model significantly improves WHO/ISUP grade prediction in ccRCC. By enhancing interpretability through SHAP analysis, this approach offers a clinically valuable tool for preoperative assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.